SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Equities researchers at Sidoti lifted their FY2026 earnings per share (EPS) estimates for shares of SBC Medical Group in a research note issued on Wednesday, November 18th. Sidoti analyst A. Shah now forecasts that the company will post earnings per share of $0.51 for the year, up from their previous estimate of $0.47. The consensus estimate for SBC Medical Group's current full-year earnings is $0.44 per share. Sidoti also issued estimates for SBC Medical Group's Q4 2026 earnings at $0.14 EPS, Q1 2027 earnings at $0.14 EPS, Q2 2027 earnings at $0.15 EPS, Q3 2027 earnings at $0.16 EPS, Q4 2027 earnings at $0.15 EPS and FY2027 earnings at $0.60 EPS.
SBC has been the subject of several other research reports. Wall Street Zen downgraded shares of SBC Medical Group from a "strong-buy" rating to a "buy" rating in a research note on Saturday, November 14th. BTIG Research boosted their target price on SBC Medical Group from $8.00 to $10.00 and gave the company a "buy" rating in a research report on Friday, November 13th. Finally, Weiss Ratings raised SBC Medical Group from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $10.00.
View Our Latest Stock Report on SBC Medical Group
SBC Medical Group Price Performance
Shares of SBC Medical Group stock opened at $6.27 on Thursday. The stock has a market cap of $644.85 million, a price-to-earnings ratio of 12.54, a price-to-earnings-growth ratio of 2.75 and a beta of 0.52. The company has a debt-to-equity ratio of 0.08, a quick ratio of 3.27 and a current ratio of 3.67. The stock has a 50 day moving average price of $5.24 and a 200-day moving average price of $4.00. SBC Medical Group has a one year low of $2.78 and a one year high of $7.39.
SBC Medical Group (NASDAQ:SBC - Get Free Report) last announced its quarterly earnings results on Friday, November 13th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.03. SBC Medical Group had a net margin of 27.26% and a return on equity of 18.58%. The company had revenue of $58.58 million for the quarter, compared to the consensus estimate of $48.90 million.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. New York State Common Retirement Fund purchased a new position in shares of SBC Medical Group in the third quarter worth about $84,000. Goldman Sachs Group Inc. acquired a new stake in shares of SBC Medical Group during the third quarter worth about $247,000. Marshall Wace LLP purchased a new stake in SBC Medical Group in the third quarter valued at approximately $520,000. State Street Corp increased its holdings in SBC Medical Group by 58.9% in the 3rd quarter. State Street Corp now owns 78,232 shares of the company's stock worth $386,000 after buying an additional 28,993 shares during the period. Finally, Russell Investments Group Ltd. increased its holdings in SBC Medical Group by 2,810.4% in the 3rd quarter. Russell Investments Group Ltd. now owns 125,991 shares of the company's stock worth $622,000 after buying an additional 121,662 shares during the period. 60.82% of the stock is currently owned by hedge funds and other institutional investors.
SBC Medical Group Company Profile
(
Get Free Report)
SBC Medical Group Holdings provides management and support services to medical institutions, with a focus on clinics offering aesthetic medicine. Its services include support for clinic operations, marketing, staff training, procurement and customer service, allowing affiliated medical providers to focus on patient care. The group is associated with the Shonan Beauty Clinic brand and a broader network of clinics offering services such as cosmetic surgery and dermatology. Its business is centered primarily in Japan, where it supports the operations and growth of affiliated medical institutions.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.